Almirall S.A. - Strategy, SWOT and Corporate Finance Report
Summary
Almirall S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Almirall S.A. (Almirall or 'the company) develops, manufactures, and markets licensed and proprietary drugs. The company develops products in the autoimmune diseases including rheumatoid arthritis and multiple sclerosis; and gastrointestinal diseases including irritable bowel syndrome with constipation. It also works in collaborations with various healthcare professionals, medical societies, and patient organizations such as The International Psoriasis Council (IPC), The European Academy of Dermatology and Venereology (EADV), The American Academy of Dermatology (AAD), The International League of Dermatological Societies (ILDS) and The Psoriasis from Gene to Clinic (Psoriasis G2C) for identifying new and innovative technologies and solutions in developing these products. The company is headquartered in Barcelona, Spain.
Scope
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook